Before the yes.
Page directoryQuestion cards · a guide to finding care
Still looking for a clinic? Start with a visit for the health problem that brought you here. Once you contact a clinic, use these questions and write down its answers.
Read the steps for finding careAsk what else could help your health concern. For any proposed treatment, ask why it fits your problem.
Peptides form short chains from the pieces used to build proteins; BPC-157 comes from a lab.
For the conversation
If an answer sounds reassuring, ask what it rests on.
At the September 2026 check, the US Food and Drug Administration (FDA) had found few studies of BPC-157 in people. Two compared BPC-157 with a pretend treatment containing no BPC-157. Neither had a full published report.
That comparison helps show whether the substance being tested makes a difference.
FDA review · human studiesThe state medical board licenses doctors and shares public records of their licences and any action taken against them for breaking its rules.
Medical boards · public recordsAs of October 30, 2026, a draft HHS policy proposes a pause in enforcement for BPC-157 made for one patient's prescription by a licensed physician or state-licensed pharmacy that meets its terms.
Federal law · pharmacy ingredientsPurity tells you how much of a tested sample is BPC-157 rather than other material. It does not tell you the strength of your dose.
At the September 2026 check, most BPC-157 test reports FDA reviewed gave a purity figure but no results for unwanted substances. Missing results do not show whether anyone tested for those substances or found them.
Ask for the report tied to the medicine you would receive. FDA’s review of other reports cannot answer that question for you.
FDA review · batch test gapsAt the September 2026 check, national advice for state medical boards was guidance for doctors, not state law.
When an online visit is not enough, the guidance requires your doctor to set up needed tests or send you to someone able to examine you.
Medical-board guidance · next stepsCost cards
Ask for the total you would pay for the visit and any proposed medicine.
At the September 2026 check, no BPC-157 medicine had FDA approval. So there was no price from a maker of an approved medicine or a government pricing program.
FDA records · no approved productThis guide has no checked estimate for what the visit and medicine would cost. Ask for each charge, whether it repeats, and the terms for cancellation. Ask the insurer what the plan would pay before counting on coverage.
Your comparison notes
Similar offers can leave different questions open. Write what was said, then keep the record you used to check it.
Your notes are not sent from this page.
When the pitch gets ahead of the proof
A confident answer still needs something you can check.
As of September 2026, FDA said made-to-order medicines were not FDA-approved, so a claim that one has that approval is false.
FDA guidance · approval wording“Research use only” is a label used on chemicals offered for lab work.
Ask separately whether you would be joining a study in people.
As of September 2026, FDA had approved no BPC-157 product for treatment in people, whatever the label said.
FDA review · product labelsBPC-157 has no FDA-approved information sheet covering pregnancy or drug interactions, the ways medicines may affect each other, as of September 2026.
Ask which parts of the answer are known, and which remain unknown.
FDA review · missing informationLoose ends worth checking
At the September 2026 check, each state set its own rules for a first online visit.
National advice for state medical boards allows some first visits through a form reviewed later, if the doctor can fully assess your care. It does not always require a live call. A form with set questions cannot be the entire visit; the doctor needs to be able to ask further questions and collect all needed information.
Medical-board guidance · online visitsRegistration is a record of a drug-making business; an entry in a drug directory is a product listing. As of September 2026, neither record proved FDA had approved the business or the drug.
FDA explanation · approval claimsUnder World Anti-Doping Agency (WADA) rules, BPC-157 is prohibited during and outside competition, as of September 2026.
WADA list · rules for competition